A New Neurocognitive Model of Complex PTSD Places the Insula at the Centre — and Explains Why Some Therapies Work
- Proposes a neurocognitive model of Complex PTSD based on active inference, positioning the insula as the central hub for understanding how C-PTSD disrupts self-identity, emotional regulation, and relationships
- Integrates limbic, salience, and prefrontal system dysfunction into a unified framework — moving beyond separate symptom cluster explanations
- Argues that MDMA-assisted therapy may work specifically because it modulates insular processing — reducing threat-based self-modelling and allowing new self-representations to form
- Provides a mechanistic rationale for why different therapies target different C-PTSD components: somatic approaches (interoception/insula), EMDR (salience network), and CBT (prefrontal regulation)
Complex PTSD has a diagnostic category (ICD-11) but not a unified neurocognitive model. We know which brain regions are involved — amygdala, prefrontal cortex, anterior cingulate. But we lack a framework that explains how prolonged trauma produces the three distinctive features of C-PTSD: affective dysregulation, negative self-concept, and disturbed relationships. This European Journal of Psychotraumatology paper proposes one, and it centres on the insula.
Why the insula matters
The insula is the brain's interoceptive hub — it processes internal body signals and constructs the felt sense of self. The model argues that in C-PTSD, the insula generates a chronic "threat-based self-model": the body is unsafe, the self is defective, others are dangerous. This is not a cognitive distortion — it is a bodily prediction that shapes perception before conscious thought occurs.
This explains why cognitive restructuring alone often fails in C-PTSD. You cannot talk a patient out of a felt sense that operates below the level of language. The model predicts that effective C-PTSD treatment must address insular processing — which is exactly what somatic approaches (Somatic Experiencing, sensorimotor psychotherapy) do.
Therapeutic implications
The model creates a map: different therapies address different network dysfunctions in C-PTSD. Somatic approaches target the insula and interoceptive processing. EMDR targets the salience network (what feels threatening). CBT targets prefrontal regulation (top-down cognitive control). MDMA-assisted therapy may work by temporarily reducing insular threat signalling, creating a window for new self-representations to form.
For clinicians treating complex trauma, this is not just theory — it is a treatment-matching framework. A patient whose primary presentation is somatic (body memories, dissociation, chronic pain) may need insula-targeted work before they can benefit from cognitive approaches. A patient whose primary presentation is cognitive (negative self-concept, shame cognitions) may respond to CBT first, with somatic work added later.
A new neurocognitive model places the insula at the centre of Complex PTSD — explaining why somatic approaches work where cognitive therapy alone often fails, and providing a treatment-matching framework for multimodal care.
Theoretical model, not empirical validation. Based on existing neuroimaging literature, not new data. The MDMA-specific claims require direct experimental testing. Model complexity may exceed what clinicians can apply without additional training.